Rugby Arthritis Pain Relieving Topical Analgesic

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name
Rugby Arthritis Pain Relieving Topical Analgesic
Generic name
CAPSAICIN
Manufacturer
Rugby Laboratories
Product type
HUMAN OTC DRUG
SPL set ID
8f1bc075-97ac-4154-8768-0d878104c3ba
SPL ID
13a863e2-701b-4175-a1ad-a12b070f578a
Version
4
Effective date
2024-03-14
Source export date
2026-10-12
Source partition
7
Source file
https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key
raw/openfda/drug-label/2026-10-12/ff22b88bd32e56cbc369af80345075227138a42b1b3ba9a84f038fd5493a7a47/drug-label-0007-of-0014.json.zip
Source manifest SHA-256
7e6b178df8f32cac9a78e0f5d09c588344509b04fe41effb1dde9102e2a45be6
Import run
20261013T011858Z
Imported at
2026-10-13 01:56:57
Harmonized routes table
Harmonized routes
TOPICAL

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings For external use only Read all warnings and directions before use. TEST FIRST ON SMALL AREA OF SKIN. Do not use on wounds or damaged skin if you are allergic to capsicum or chili peppers When using this product you may experience a burning sensation. The intensity of this reaction varies among individuals and may be severe. With regular use, this sensation generally disappears after several days. avoid contact with eyes, lips, nose and mucous membranes do not tightly wrap or bandage the treated area do not apply heat to the treated area immediately before or after use Stop and ask a doctor if condition worsens or does not improve after regular use severe burning persists or blistering occurs Keep out of reach of children . If swallowed, get medical help or contact a Poison Control Center immediately. If pregnant or breast feeding , ask a health professional before use.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.